Have we been qualifying measurable residual disease correctly?
Feng Y, Qi S, Liu X, Zhang L, Hu Y, Shen Q, Gong X, Zhang W, Wang J, Yan W, Wang T, Wang H, Song Z, Zhu X, Gale RP, Chen J.
Feng Y, et al. Among authors: qi s.
Leukemia. 2023 Sep 13. doi: 10.1038/s41375-023-02026-4. Online ahead of print.
Leukemia. 2023.
PMID: 37704711
Review.
No abstract available.